Stock Events

Stock Events

Dexcom 

R$7.11
530
-R$0.13-1.8% Monday 13:51

Statistics

Day High
7.11
Day Low
7.1
52W High
10.06
52W Low
5.75
Volume
11
Avg. Volume
-
Mkt Cap
2.74B
P/E Ratio
225.8
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.32
0.44
0.56
0.68
Expected EPS
0.607354
Actual EPS
N/A

Financials

17.89%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
51.27BRevenue
9.17BNet Income

Analyst Ratings

143.03Average Price Target
The highest estimate is 161.71.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
90%
Hold
0%
Sell
10%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow D1EX34.SA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap152.25B
Abbott Laboratories competes with Dexcom in the continuous glucose monitoring (CGM) market, particularly with their FreeStyle Libre system.
Medtronic
MDT
Mkt Cap100.91B
Medtronic is a direct competitor in the CGM and diabetes management market, offering products like the Guardian Connect system.
Tandem Diabetes Care
TNDM
Mkt Cap1.03B
Tandem Diabetes Care partners with Dexcom for CGM integration but also competes in providing comprehensive diabetes management solutions.
Insulet
PODD
Mkt Cap10.73B
Insulet Corporation's Omnipod system is a competitor in the broader diabetes management space, offering an alternative to traditional insulin delivery and monitoring systems.
Senseonics
SENS
Mkt Cap330.97M
Senseonics Holdings offers the Eversense CGM system, providing long-term implantable glucose monitoring, a direct competitor to Dexcom's wearable CGM products.
Novo Nordisk
NVO
Mkt Cap199.25B
Novo Nordisk competes indirectly through their extensive range of diabetes care products, including insulin and non-insulin treatments, which are part of integrated diabetes management.
Sanofi
SNY
Mkt Cap105.85B
Sanofi competes in the diabetes market with its insulin and glucose monitoring solutions, offering an alternative to Dexcom's CGM systems.
Mckesson
MCK
Mkt Cap92.09B
McKesson Corporation, through its distribution of diabetes care products including CGMs, competes in the broader market for diabetes management solutions.
Cardinal Health
CAH
Mkt Cap47B
Cardinal Health is involved in the distribution of various healthcare products, including diabetes care supplies, competing in the broader market for diabetes management.

About

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Kevin Ronald Sayer
Employees
6300
Country
United States
ISIN
BRD1EXBDR004

Listings

STU
DE
DC4.STU
SA
BR
D1EX34.SA
MU
DE
DC4.MU
MI
IT
1DXCM.MI

0 Comments

Share your thoughts

FAQ

What is Dexcom stock price today?▼
The current price of D1EX34.SA is R$7.11 BRL — it has decreased by -1.8% in the past 24 hours. Watch Dexcom stock price performance more closely on the chart.
What is Dexcom stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dexcom stocks are traded under the ticker D1EX34.SA.
Is Dexcom stock price growing?▼
D1EX34.SA stock has risen by +4.56% compared to the previous week, the month change is a +15.24% rise, over the last year Dexcom has showed a -24.84% decrease.
What is Dexcom market cap?▼
Today Dexcom has the market capitalization of 2.74B
When is the next Dexcom earnings date?▼
Dexcom is going to release the next earnings report on July 23, 2026.
What were Dexcom earnings last quarter?▼
D1EX34.SA earnings for the last quarter are 2.78 BRL per share, whereas the estimation was 2.31 BRL resulting in a +20.27% surprise. The estimated earnings for the next quarter are N/A BRL per share.
What is Dexcom revenue for the last year?▼
Dexcom revenue for the last year amounts to 51.27B BRL.
What is Dexcom net income for the last year?▼
D1EX34.SA net income for the last year is 9.17B BRL.
How many employees does Dexcom have?▼
As of May 26, 2026, the company has 6,300 employees.
In which sector is Dexcom located?▼
Dexcom operates in the Health & Wellness sector.
When did Dexcom complete a stock split?▼
The last stock split for Dexcom was on June 13, 2022 with a ratio of 4:1.
Where is Dexcom headquartered?▼
Dexcom is headquartered in San Diego, United States.